네트워크 약리학을 활용한 메니에르병에 대한 二陳湯의 활성 성분과 치료 기전 연구(Ⅱ)
Analysis of the Active Compounds and Therapeutic Mechanisms of Yijin-tang on Meniere's Disease Using Network Pharmacology(Ⅱ)
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives : This study used a network pharmacology approach to analyze the treatment mechanisms of Yijin-tang on Meniere's disease, and comparative analysis the treatment mechanisms of drugs recommended in the Meniere's disease treatment guidelines. Methods : We collected information on the recommended drugs from the Meniere's disease treatment guidelines and their target proteins were screened via the STITCH database. The intersection targets were obtained through Venny 2.1.0. Gene Ontology(GO) analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis were performed using ClueGO. Results : The 7 proteins(TNF, CASP9, PARP1, CCL2, CFTR, NOS2, NOS1) were associated with both Yijin-tang and Meniere's disease related genes. The 10 proteins(AQP2, KCNE1, AQP1, AVP, ACE, HRH1, HRH3, NOS1, CA1, CFTR) were associated with both the recommended drugs in the guidelines and Meniere's disease related genes. The 2 proteins(CFTR, NOS1) were common across all three groups. Further, GO/KEGG pathway analysis of the collected proteins revealed that the common mechanisms of action between Yijin-tang and the recommended drugs in the guidelines were related to pathways involving immune dysfunction and disturbances in lymphatic fluid homeostasis. In addition, the recommended drugs in the guidelines appeared to act through mechanisms that improve blood flow through vasodilation. Conclusions : Pharmacological network analysis can help to explain the treatment mechanisms of Yijin-tang on Meniere's disease.
Abstract
Objectives : This study used a network pharmacology approach to analyze the treatment mechanisms of Yijin-tang on Meniere's disease, and comparative analysis the treatment mechanisms of drugs recommended in the Meniere's disease treatment guidelines. Methods : We collected information on the recommended drugs from the Meniere's disease treatment guidelines and their target proteins were screened via the STITCH database. The intersection targets were obtained through Venny 2.1.0. Gene Ontology(GO) analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis were performed using ClueGO. Results : The 7 proteins(TNF, CASP9, PARP1, CCL2, CFTR, NOS2, NOS1) were associated with both Yijin-tang and Meniere's disease related genes. The 10 proteins(AQP2, KCNE1, AQP1, AVP, ACE, HRH1, HRH3, NOS1, CA1, CFTR) were associated with both the recommended drugs in the guidelines and Meniere's disease related genes. The 2 proteins(CFTR, NOS1) were common across all three groups. Further, GO/KEGG pathway analysis of the collected proteins revealed that the common mechanisms of action between Yijin-tang and the recommended drugs in the guidelines were related to pathways involving immune dysfunction and disturbances in lymphatic fluid homeostasis. In addition, the recommended drugs in the guidelines appeared to act through mechanisms that improve blood flow through vasodilation. Conclusions : Pharmacological network analysis can help to explain the treatment mechanisms of Yijin-tang on Meniere's disease.
참고문헌 (21)
- Harris JP, "Current-day prevalence of Meniere’s syndrome", Audiology and Neurotology, 15(5), pp.318~322 (2010)
- Kim MH, "Epidemiology and seasonal variation of Ménière’s disease : Data from a population-based study", Audiology and Neurotology, 25(4), pp.224~230 (2020)
- Basura GJ, "Clinical practice guideline : Ménière’s disease", Otolaryngology–Head and Neck Surgery, 162(S2), pp.S1~55 (2020)
- Jung SC, "The bibliographicol study on Yijin-tang(sang)", Journal of Haehwa Medicine, 11(1), pp.29~41 (2002)
- Park WH, "The bibliographicol study on Dam-Eum", The Journal of Dong Guk Oriental Medicine, 1(1), pp.141~160 (1992)
- 정혜진, "메니에르 병의 병리기전에 대한 최신 연구 동향과 한의학적 고찰", 한방안이비인후피부과학회지, 30(3), pp.103~118 (2017), 대한한방안이비인후피부과학회[DOI]
- 진선경, "네트워크 약리학을 활용한 메니에르병에 대한 二陳湯의 활성 성분과 치료 기전 연구(Ⅰ)", 한방안이비인후피부과학회지, 36(1), pp.50~63 (2023), 대한한방안이비인후피부과학회
- Barrette LX, "A systematic quality appraisal of clinical practice guidelines for Ménière’s disease using the AGREE II instrument", European Archives of Oto-Rhino-Laryngology, 279(7), pp.3439~3447 (2022)
- Magnan J, "European position statement on diagnosis, and treatment of Meniere’s disease", The journal of international advanced otology, 14(2), pp.317~321 (2018)
- Nevoux J, "Diagnostic and therapeutic strategy in Menière's disease. Guidelines of the French Otorhinolaryngology-Head and Neck Surgery Society(SFORL)", European annals of otorhinolaryngology head and neck diseases, 134(6), pp.441~444 (2017)
- Nevoux J, "International consensus(ICON)on treatment of Ménière's disease", European annals of otorhinolaryngology head and neck diseases, 135(1S), pp.S29~S32 (2018)
- Iwasaki S, "Diagnostic and therapeutic strategies for Meniere's disease of the Japan Society for Equilibrium Research", Auris Nasus Larynx, 48(1), pp.15~22 (2021)
- "Meniere’s disease" (2022)[URL]
- 한승희, "가미반하백출천마탕 및 한의치료로 호전된 어지럼 환자 4례", 대한한방내과학회지, 40(5), pp.967~973 (2019), 대한한방내과학회[DOI]
- 장수영, "메니에르 병 환자의 虛實別 치험례", 대한한방내과학회지, 32(1), pp.121~128 (2011), 대한한방내과학회
- 이규진, "메니에르 환자 치험 2례", 한방안이비인후피부과학회지, 18(3), pp.158~164 (2005), 대한한방안이비인후피부과학회
- Lee SE, "Oriental medical treatment in Meniere's disease", The Journal of Korean Acupuncture & Moxibustion Society, 21(6), pp.269~279 (2004)
- 박준영, "메니에르 병 치험 1례", 한방안이비인후피부과학회지, 19(2), pp.288~295 (2006), 대한한방안이비인후피부과학회
- Bertlich M, "Histaminergic H3-heteroreceptors as a potential mediator of betahistine-induced increase in cochlear blood flow", Audiology and Neurotology, 20(5), pp.283~293 (2015)
- Harcourt J, "Meniere’s disease", BMJ, 349(7), pp.6544~ (2014)
- Van-Esch B, "Betahistine in Meniere's disease or syndrome : A Systematic Review", Audiol Neurootol, 27(1), pp.1~33 (2022)